Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer

Science of the Total Environment

Volumn 468-469, Issue , 2014, Pages 384-393

  Schaider, Laurel A ^a   Rudel, Ruthann A ^a   Ackerman, Janet M ^a   Dunagan, Sarah C ^a   Brody, Julia Green ^a  

^a Silent Spring Institute   (United States)

Author keywords

Groundwater; Non point source pollution; Organic wastewater compounds; Perfluorinated chemicals; Pharmaceuticals; Septic systems

Indexed keywords

ANTIBIOTICS; AQUIFERS; DRUG PRODUCTS; EFFLUENTS; GROUNDWATER; GROUNDWATER RESOURCES; HEALTH RISKS; HYDROGEOLOGY; MINING LAWS AND REGULATIONS; ORGANIC CHEMICALS; SEPTIC TANKS; SEWAGE PUMPING PLANTS; TOXICITY; WATER TREATMENT PLANTS;

MAXIMUM CONCENTRATIONS; NON-POINT SOURCE POLLUTION; ORGANIC WASTEWATER COMPOUNDS; PERFLUORINATED CHEMICALS; PERFLUOROOCTANE SULFONATES; SEPTIC SYSTEM; WASTEWATER TREATMENT PLANT EFFLUENT; WASTEWATER TREATMENT PLANTS;

GROUNDWATER POLLUTION;

BORON; DRINKING WATER; DRUG; NITRATE; ORGANIC COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROSURFACTANT; PHENYTOIN; SULFAMETHOXAZOLE; SURFACTANT; UNCLASSIFIED DRUG; WELL WATER;

AQUIFER; ARTESIAN WELL; CONCENTRATION (COMPOSITION); DRINKING WATER; DRUG; GROUNDWATER POLLUTION; GUIDELINE; HEALTH RISK; NONPOINT SOURCE POLLUTION; ORGANIC POLLUTANT; SURFACTANT; TESTING METHOD; TOXICITY; WASTEWATER; WATER SUPPLY;

AQUIFER; ARTICLE; COMMERCIAL PHENOMENA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; GRAVEL; PRIORITY JOURNAL; SAND; SEPTIC SYSTEM; SOIL; UNITED STATES; WASTE WATER; WASTE WATER MANAGEMENT; WATER SAMPLING;

CAPE COD; MASSACHUSETTS; UNITED STATES;

GROUNDWATER; NON-POINT SOURCE POLLUTION; ORGANIC WASTEWATER COMPOUNDS; PERFLUORINATED CHEMICALS; PHARMACEUTICALS; SEPTIC SYSTEMS;

CHEMISTRY TECHNIQUES, ANALYTICAL; DRINKING WATER; ENVIRONMENTAL MONITORING; FLUOROCARBONS; GROUNDWATER; MASSACHUSETTS; PHARMACEUTICAL PREPARATIONS; SURFACE-ACTIVE AGENTS; WATER POLLUTANTS, CHEMICAL; WATER WELLS;

EID: 84884251715     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.08.067     Document Type: Article

References (88)

1. Ahel M., Conrad T., Giger W. Persistent organic chemicals in sewage effluents. 3. Determinations of nonylphenoxy carboxylic acids by high-resolution gas-chromatography/mass spectrometry and high-performance liquid chromatography. Environ Sci Technol 1987, 21:697-703.
2. Andresen J.A., Grundmann A., Bester K. Organophosphorus flame retardants and plasticisers in surface waters. Sci Total Environ 2004, 332:155-166.
3. Barber L.B. Sorption of chlorobenzenes to Cape Cod aquifer sediments. Environ Sci Technol 1994, 28:890-897.
4. Barber L.B. Fate of consumer-product chemicals in the subsurface environment: twenty-five years of research on Cape Cod, Massachusetts, USA. Proceedings of the 6th International Groundwater Quality Conference; 2007 2008, 126-132. IAHS Publ, Fremantle, Western Australia. M.G. Trefry (Ed.).
5. Barber L.B., Thurman E.M., Schroeder M.P., LeBlanc D.R. Long-term fate of organic micropollutants in sewage-contaminated groundwater. Environ Sci Technol 1988, 22:205-211.
6. Barber L.B., Keefe S.H., Leblanc D.R., Bradley P.M., Chapelle F.H., Meyer M.T., et al. Fate of sulfamethoxazole, 4-nonylphenol, and 17 beta-estradiol in groundwater contaminated by wastewater treatment plant effluent. Environ Sci Technol 2009, 43:4843-4850.
7. Barlow P.M. Two and three-dimensional pathline analysis of contributing areas to public-supply wells of Cape Cod, Massachusetts. Ground Water 1994, 32:399-410.
8. Barnes K.K., Kolpin D.W., Furlong E.T., Zaugg S.D., Meyer M.T., Barber L.B. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States - I. Groundwater. Sci Total Environ 2008, 402:192-200.
9. Barrett M.H., Hiscock K.M., Pedley S., Lerner D.N., Tellam J.H., French M.J. Marker species for identifying urban groundwater recharge sources: a review and case study in Nottingham, UK. Water Res 1999, 33:3083-3097.
10. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2009, 43:597-603.
11. Bradbury K.R., Borchardt M.A., Gotkowitz M., Spencer S.K., Zhu J., Hunt R.J. Source and transport of human enteric viruses in deep municipal water supply wells. Environ Sci Technol 2013, 47:4096-4103.
12. Brian J.V., Harris C.A., Scholze M., Kortenkamp A., Booy P., Lamoree M., et al. Evidence of estrogenic mixture effects on the reproductive performance of fish. Environ Sci Technol 2007, 41:337-344.
13. Brody J.G., Aschengrau A., McKelvey W., Swartz C.H., Kennedy T., Rudel R.A. Breast cancer risk and drinking water contaminated by wastewater: a case control study. Environ Health 2006, 5:28.
14. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 2010, 44:5619-5626.
15. Buerge I.J., Buser H.R., Kahle M., Muller M.D., Poiger T. Ubiquitous occurrence of the artificial sweetener acesulfame in the aquatic environment: an ideal chemical marker of domestic wastewater in groundwater. Environ Sci Technol 2009, 43:4381-4385.
16. Cape Cod Commission Regional Wastewater Management Plan, technology assessment - conventional infrastructure. Barnstable (MA) 2013, [Available from: http://www.capecodcommission.org/resources/RWMP/RWMP_ta_conventional.pdf].
17. Cape Cod Commission [Internet]. Barnstable (MA): Watershed MVP (Watershed Multi-Variant Planner); 2013b. [cited March 31, 2013]. Available from: http://www.watershedmvp.org.
18. Carrara C., Ptacek C.J., Robertson W.D., Blowes D.W., Moncur M.C., Sverko E., et al. Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. Environ Sci Technol 2008, 42:2805-2811.
19. Celiz M.D., Tso J., Aga D.S. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environ Toxicol Chem 2009, 28:2473-2484.
20. Cole M.L., Kroeger K.D., McClelland J.W., Valiela I. Effects of watershed land use on nitrogen concentrations and delta(15) nitrogen in groundwater. Biogeochemistry 2006, 77:199-215.
21. Dishaw L.V., Powers C.M., Ryde I.T., Roberts S.C., Seidler F.J., Slotkin T.A., et al. Is the PentaBDE replacement, tris (1,3-dichloropropyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells. Toxicol Appl Pharmacol 2011, 256:281-289.
22. Dong Z., Senn D.B., Moran R.E., Shine J.P. Prioritizing environmental risk of prescription pharmaceuticals. Regul Toxicol Pharmacol 2013, 65:60-67.
23. Egeghy P.P., Lorber M. An assessment of the exposure of Americans to perfluorooctane sulfonate: a comparison of estimated intake with values inferred from NHANES data. J Expo Anal Environ Epidemiol 2011, 21:150-168.
24. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., et al. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II. Untreated drinking water sources. Sci Total Environ 2008, 402:201-216.
25. Gallagher L.G., Webster T.F., Aschengrau A., Vieira V.M. Using residential history and groundwater modeling to examine drinking water exposure and breast cancer. Environ Health Perspect 2010, 118:749-755.
26. Godfrey E., Woessner W.W., Benotti M.J. Pharmaceuticals in on-site sewage effluent and ground water, western Montana. Ground Water 2007, 45:263-271.
27. Grandjean P., Budtz-Jørgensen E. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health 2013, 12:35.
28. Guo Y.C., Krasner S.W. Occurrence of primidone, carbamazepine, caffeine, and precursors for n-nitrosodimethylamine in drinking water sources impacted by wastewater. J Am Water Res Assoc 2009, 45:58-67.
29. Haack S.K., Metge D.W., Fogarty L.R., Meyer M.T., Barber L.B., Harvey R.W., et al. Effects on groundwater microbial communities of an engineered 30-day in situ exposure to the antibiotic sulfamethoxazole. Environ Sci Technol 2012, 46:7478-7486.
30. Hoppe-Jones C., Dickenson E.R.V., Drewes J.E. The role of microbial adaptation and biodegradable dissolved organic carbon on the attenuation of trace organic chemicals during groundwater recharge. Sci Total Environ 2012, 437:137-144.
31. Huntsman B.E., Staples C.A., Naylor C.G., Williams J.B. Treatability of nonylphenol ethoxylate surfactants in on-site wastewater disposal systems. Water Environ Res 2006, 78:2397-2404.
32. ICH Geneva, Switzerland: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Testing Guidelines, Safety Guidelines 2013, [cited March 31, 2013], [Available from: http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html].
33. Illinois EPA Report on Pharmaceuticals and Personal Care Products in Illinois Drinking Water Springfield (IL): Illinois Environmental Protection Agency Available from:. http://www.epa.state.il.us/water/pharmaceuticals-in-drinking-water.pdf.
34. Johnson T.D., Belitz K. Assigning land use to supply wells for the statistical characterization of regional groundwater quality: correlating urban land use and VOC occurrence. J Hydrol 2009, 370:100-108.
35. Kingsbury J.A., Delzer G.C., Hopple J.A. Anthropogenic organic compounds in source water of nine community water systems that withdraw from streams, 2002-05. Report No.: Scientific Investigations Report 2008-5208 2008, U.S. Geological Survey, Reston (VA).
36. Kolpin D.W. Agricultural chemicals in groundwater of the Midwestern United States: relations to land use. J Environ Qual 1997, 26:1025-1037.
37. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
38. Kristensen D.M., Hass U., Lesne L., Lottrup G., Jacobsen P.R., Desdoits-Lethimonier C., et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011, 26:235-244.
39. Kumar A., Chang B., Xagoraraki I. Human health risk assessment of pharmaceuticals in water: issues and challenges ahead. Int J Environ Res Public Health 2010, 7:3929-3953.
40. LeBlanc D.R. Sewage plume in a sand and gravel aquifer, Cape Cod, Massachusetts. Report No.: Water-Supply Paper 2218 1984, U.S. Geological Survey, Washington, DC.
41. Loos R., Locoro G., Comero S., Contini S., Schwesig D., Werres F., et al. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res 2010, 44:4115-4126.
42. Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Env Epid 2008, 18:2-19.
43. Massachusetts EOEA Cape Cod watershed assessment and 5-year action plan 2004, Commonwealth of Massachusetts, Executive Office of Environmental Affairs, Boston, MA, [Available from: http://www.mass.gov/eea/docs/eea/water/wap-capecod.pdf].
44. Massachusetts IT Division [internet] Massachusetts geographic information system 2012, Commonwealth of Massachusetts, Information Technology Division, Boston (MA), [[cited January 27, 2012], Available from: http://www.mass.gov/mgis/massgis.htm].
45. McCoy M. Going green: pushed by Wal-Mart, legislators, and the public, the cleaning products industry embraces sustainability. Chem Eng News 2007, 85:13-19.
46. Meylan W.M., Howard P.H. Atom/fragment contribution method for estimating octanol-water partition coefficients. J Pharm Sci 1995, 84:83-92.
47. Miller J.A. Ground water atlas of the United States: introduction and national summary. Report No.: Hydrologic Atlas 730 1999, U.S. Geological Survey, Office of Ground Water, Reston (VA), [Available from: http://pubs.usgs.gov/ha/ha730/ch_a/index.html].
48. Minnesota DOH Health risk limits for groundwater 2008 rule revision, perfluorooctanoic acid 2008, Minnesota Department of Health, Health Risk Assessment Unit, Environmental Health Division, St. Paul (MN), [Available from: http://www.health.state.mn.us/divs/eh/risk/guidance/gw/pfoa.pdf].
49. Minnesota DOH Health risk limits for perfluorochemicals: report to the Minnesota legislature 2008, Minnesota Department of Health, Environmental Surveillance and Assessment Section, Environmental Health Division, St. Paul (MN), [Available from: http://www.health.state.mn.us/divs/eh/hazardous/topics/pfcs/finalreport011508.pdf].
50. Minnesota DOH 2011 Health based value for groundwater: carbamazepine 2011, Minnesota Department of Health, Health Risk Assessment Unit, Environmental Health Division, St. Paul (MN), [Available from: http://www.health.state.mn.us/divs/eh/risk/guidance/gw/carbamazepine.pdf].
51. Minnesota DOH 2012 Health based value for groundwater, N, n-diethyl-3-methylbenzamide (DEET) 2012, Minnesota Department of Health, Health Risk Assessment Unit, Environmental Health Division, St. Paul (MN), [Available from: http://www.health.state.mn.us/divs/eh/risk/guidance/gw/deet.pdf].
52. Moody C.A., Hebert G.N., Strauss S.H., Field J.A. Occurrence and persistence of perfluorooctanesulfonate and other perfluorinated surfactants in groundwater at a fire-training area at Wurtsmith Air Force Base, Michigan, USA. J Environ Monitor 2003, 5:341-345.
53. NJDEP Determination of perfluorooctanic acid (PFOA) in aqueous samples: final report 2007, New Jersey Department of Environmental Protection, Division of Water Supply, Trenton (NJ), [Available from: http://slic.njstatelib.org/slic_files/digidocs/w329/w3292007.pdf].
54. NRMMC Australian guidelines for water recycling: managing health and environmental risks (Phase 2), augmentation of drinking water supplies 2008, Natural Resource Management Ministerial Council, Environment Protection and Heritage Council, National Health and Medical Research Council, Canberra, Australia, [Available from: http://www.ephc.gov.au/sites/default/files/WQ_AGWR_GL__ADWS_Corrected_Final_%20200809.pdf].
55. Post G.B., Louis J.B., Cooper K.R., Boros-Russo B.J., Lippincott R.L. Occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems. Environ Sci Technol 2009, 43:4547-4554.
56. Quiñones O., Snyder S.A. Occurrence of perfluoroalkyl carboxylates and sulfonates in drinking water utilities and related waters from the United States. Environ Sci Technol 2009, 43:9089-9095.
57. Reddy S., Iden C.R., Brownawell B.J. Analysis of steroid conjugates in sewage influent and effluent by liquid chromatography-tandem mass spectrometry. Anal Chem 2005, 77:7032-7038.
58. Reemtsma T., Quintana J.B., Rodil R., Garcia-Lopez M., Rodriguez I. Organophosphorus flame retardants and plasticizers in water and air: I. Occurrence and fate. Trac-Trends Anal Chem 2008, 27:727-737.
59. Rudel R.A., Geno P., Melly S.J., Sun G., Brody J.G. Identification of alkylphenols and other estrogenic phenolic compounds in wastewater, septage, and groundwater on Cape Cod, Massachusetts. Environ Sci Technol 1998, 32:861-869.
60. Saito N., Harada K., Inoue K., Sasaki K., Yoshinaga T., Koizumi A. Perfluorooctanoate and perfluorooctane sulfonate concentrations in surface water in Japan. J Occup Health 2004, 46:49-59.
61. Schreiber I.M., Mitch W.A. Occurrence and fate of nitrosamines and nitrosamine precursors in wastewater-impacted surface waters using boron as a conservative tracer. Environ Sci Technol 2006, 40:3203-3210.
62. Seiler R.L., Zaugg S.D., Thomas J.M., Howcroft D.L. Caffeine and pharmaceuticals as indicators of wastewater contamination in wells. Ground Water 1999, 37:405-410.
63. Shin H.M., Vieira V.M., Ryan P.B., Detwiler R., Sanders B., Steenland K., et al. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia. Environ Sci Technol 2011, 45:1435-1442.
64. Silent Spring Institute Cape Cod Breast Cancer and Environment Study: Final report, December 8, 1997. Newton (MA) 1997.
65. Standley L.J., Rudel R.A., Swartz C.H., Attfield K.R., Christian J., Erickson M., et al. Wastewater-contaminated groundwater as a source of endogenous hormones and pharmaceuticals to surface water ecosystems. Environ Toxicol Chem 2008, 27:2457-2468.
66. Stanford B.D., Weinberg H.S. Evaluation of on-site wastewater treatment technology to remove estrogens, nonylphenols, and estrogenic activity from wastewater. Environ Sci Technol 2010, 44:2994-3001.
67. State Cancer Profiles [internet] Incidence rate report for Massachusetts by county, 2005-2009 2013, National Cancer Institute, [[cited May 15, 2013]. Available from: http://statecancerprofiles.cancer.gov/cgi-bin/quickprofiles/profile.pl?25&055].
68. Stephenson J. Observations on improving the Toxic Substances Control Act. Report No.: GAO-10-292T 2009, U.S. General Accounting Office, Washington, DC, [Available from: http://www.gao.gov/assets/130/123792.pdf].
69. Swartz C.H., Reddy S., Benotti M.J., Yin H., Barber L.B., Brownawell B.J., et al. Steroid estrogens, nonylphenol ethoxylate metabolites, and other wastewater contaminants in groundwater affected by a residential septic system on Cape Cod, MA. Environ Sci Technol 2006, 40:4894-4902.
70. Tabe S. Occurrence and removal of PPCPs and EDCs in the Detroit River watershed. Water Practice Technol 2010, 5:1-8.
71. Trudel D., Horowitz L., Wormuth M., Scheringer M., Cousins I.T., Hungerbuhler K. Estimating consumer exposure to PFOS and PFOA. Risk Anal 2008, 28:251-269.
72. Underwood J.C., Harvey R.W., Metge D.W., Repert D.A., Baumgartner L.K., Smith R.L., et al. Effects of the antimicrobial sulfamethoxazole on groundwater bacterial enrichment. Environ Sci Technol 2011, 45:3096-3101.
73. US Census Bureau American housing survey for the United States: 2009. Report No.: H150/09 2011, U.S. Government Printing Office, Washington, DC, [Available from: http://www.census.gov/prod/2011pubs/h150-09.pdf].
74. US EPA Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.10, KOWWIN v 1.68 2000, U.S. Environmental Protection Agency, Washington, DC.
75. US EPA Factoids: drinking water and ground water statistics for 2009. Report No. EPA 816-K-09-004 2009, US Environmental Protection Agency, Office of Water, Washington, DC, [Available from: http://www.epa.gov/safewater/databases/pdfs/data_factoids_2009.pdf].
76. US EPA Provisional health advisories for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) 2009, Environmental Protection Agency, Office of Water, Washington, DC, [Available from: http://water.epa.gov/action/advisories/drinking/upload/2009_01_15_criteria_drinking_pha-PFOA_PFOS.pdf].
77. US EPA Region 3 Regional Screening Level (RSL) summary table November 2012, U.S. Environmental Protection Agency, Mid-Atlantic Risk Assessment, Philadelphia (PA), [Available from: http://www.epa.gov/reg3hwmd/risk/human/rb-concentration_table/index.htm].
78. US FDA Septra tablets (trimethoprim and sulfamethoxazole) prescribing information 2008, U.S. Food and Drug Administration, Silver Spring (MD), [Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017376s058,017598s040,018452s025lbl.pdf].
79. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012, 33:378-455.
80. Vanderford B.J., Snyder S.A. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 2006, 40:7312-7320.
81. Vengosh A., Heumann K.G., Juraske S., Kasher R. Boron isotope application for tracing sources of contamination in groundwater. Environ Sci Technol 1994, 28:1968-1974.
82. Verstraeten I.M., Fetterman G.S., Meyer M.T., Bullen T., Sebree S.K. Use of tracers and isotopes to evaluate vulnerability of water in domestic wells to septic waste. Ground Water Monit Remediat 2005, 25:107-117.
83. Vestergren R., Cousins I.T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ Sci Technol 2009, 43:5565-5575.
84. Waggott A. An investigation of potential problem of increasing boron concentrations in rivers and water courses. Water Res 1969, 3:749-765.
85. WHO Pharmaceuticals in drinking-water. Report No.: WHO/HSE/WSH/11.05 2011, World Health Organization, Geneva, Switzerland, [Available from: http://www.who.int/water_sanitation_health/publications/2011/pharmaceuticals_20110601.pdf].
86. WHO/UNEP State of the science of endocrine disrupting chemicals - 2012 2013, United Nations Environment Programme and the World Health Organization, Inter-Organization Programme for the Sound Management of Chemicals, Geneva, Switzerland, [Available from: http://www.who.int/ceh/publications/endocrine/en/index.html]. A. Bergman, J.J. Heindel, S. Jobling, K.A. Kidd, R.T. Zoeller (Eds.).
87. Wilcox J.D., Bahr J.M., Hedman C.J., Hemming J.D.C., Barman M.A.E., Bradbury K.R. Removal of organic wastewater contaminants in septic systems using advanced treatment technologies. J Environ Qual 2009, 38:149-156.
88. Zimmerman M.J. Occurrence of organic wastewater contaminants, pharmaceuticals, and personal care products in selected water supplies, Cape Cod, Massachusetts, June 2004. Report No.: Open-File Report 2005-1206 2005, U.S. Geological Survey, Reston (VA).